Robbins Wendye 4
4 · RAPT Therapeutics, Inc. · Filed Mar 15, 2023
Insider Transaction Report
Form 4
Robbins Wendye
Director
Transactions
- Purchase
Common Stock
2023-03-14$18.48/sh+400$7,392→ 14,300 total - Purchase
Common Stock
2023-03-14$19.95/sh+600$11,970→ 14,900 total - Purchase
Common Stock
2023-03-14$20.05/sh+2,500$50,125→ 6,500 total(indirect: By Spouse) - Purchase
Common Stock
2023-03-14$18.75/sh+1,500$28,125→ 13,900 total
Holdings
- 6,100(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The total number of shares has been adjusted to correct an inadvertent mathematical error in the total number of shares beneficially owned by the Reporting Person in the prior Form 4s.
- [F2]The Reporting Person no longer has a reportable beneficial interest in 305 shares of the Issuer's common stock owned by her daughter and included in the Reporting Person's prior ownership reports.